Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Aiko Fujioka"'
Autor:
Hiroyuki Yamada, Masaaki Inaba, Yoshihiro Sugiura, Kazutsune Harada, Atsuto Inoue, Masanori Emoto, Tomoe Hirakawa, Mikiyasu Taguchi, Ikue Kobayashi, Noriyuki Hayashi, Yasuo Imanishi, Daichi Miyaoka, Aiko Fujioka
Publikováno v:
Journal of Bone and Mineral Metabolism. 39:396-403
Etelcalcetide (Parsabiv®, AMG 416/ONO-5163) is a novel allosteric modulator for the calcium-sensing receptor approved for hemodialysis patients with secondary hyperparathyroidism of uremia. Etelcalcetide reduced parathyroid hormone levels in hemodia
Autor:
Kazutsune Harada, Yasushi Hirota, Aiko Fujioka, Hiroyuki Yamada, Masakazu Konno, Atsuto Inoue
Publikováno v:
European Journal of Pharmacology. 842:139-145
Etelcalcetide hydrochloride (Parsabiv®, ONO-5163/AMG 416) is an allosteric modulator of the calcium (Ca)-sensing receptor that was originally produced by KAI Pharmaceuticals Inc. (now Amgen Inc.). It has recently been approved as the first intraveno
Autor:
Atsuto Inoue, Yasuo Imanishi, Daichi Miyaoka, Mikiyasu Taguchi, Hiroyuki Yamada, Sugiura Yoshihiro, Kazutsune Harada, Aiko Fujioka, Noriyuki Hayashi
Publikováno v:
Nephrology Dialysis Transplantation. 34
Autor:
Kazutsune, Harada, Aiko, Fujioka, Masakazu, Konno, Atsuto, Inoue, Hiroyuki, Yamada, Yasushi, Hirota
Publikováno v:
European journal of pharmacology. 842
Etelcalcetide hydrochloride (Parsabiv
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 91(5)